DANAZOL 200 MG CAPSULES - AUE DG 1092
About This Opportunity
TranslatedThis tender pertains to the procurement of Danazol 200 mg capsules, identified by the reference AUE DG 1092. Danazol is a synthetic steroid derivative used to treat several conditions, including endometriosis, fibrocystic breast disease, and hereditary angioedema. It functions by suppressing the pituitary gland's production of gonadotropins (luteinizing hormone and follicle-stimulating hormone), thereby reducing estrogen and progesterone levels. The specified dosage is 200 mg per capsule. The reference 'AUE DG 1092' likely indicates a specific product code, batch, or internal reference number relevant to the procuring entity's inventory or regulatory requirements. The tender seeks to secure a supply of this medication to meet patient needs for these specific gynecological and immunological conditions. Evaluation criteria will likely focus on the quality and efficacy of the Danazol capsules, pricing, delivery reliability, and compliance with pharmaceutical manufacturing standards. The successful bidder will be responsible for providing the specified Danazol capsules, ensuring they meet all regulatory and quality specifications. This procurement is essential for providing therapeutic options for conditions that significantly impact women's health and well-being.
This is a supplies contract in the health and medical services, information and communication technology and transport and logistics sectors, with a focus on Pharmaceuticals and Logistics. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 265.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender seeks the supply of Danazol 200 mg capsules, identified by the reference AUE DG 1092. The procurement is being conducted within Portugal and will be managed through the BASE portal, which serves as the central repository for public contract information across mainland Portugal and its autonomous regions. This initiative falls under public procurement, aiming to secure essential pharmaceutical supplies for healthcare services or related public entities.
Suppliers are invited to submit bids for the provision of Danazol 200 mg capsules. Typical requirements for such tenders include demonstrating the ability to supply pharmaceutical products meeting stringent quality and regulatory standards, including relevant Good Manufacturing Practice (GMP) certifications. Bidders will likely need to provide comprehensive product specifications, evidence of regulatory approval from competent authorities, and detail their supply chain and logistics capabilities to ensure timely and reliable delivery. Furthermore, proposals will generally be evaluated based on factors such as price, quality assurance, delivery timelines, and the supplier's capacity to meet the specified quantities. Compliance with all applicable national and European Union pharmaceutical regulations is paramount. The contracting authority, though not explicitly named in the provided detail, will be a public entity operating under Portuguese jurisdiction.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 10, 2026. Last refreshed 10 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Almada-Seixal, EPE
Unidade Local de Saúde de Almada-Seixal, EPE has issued 1,414 procurement notices on BidsFactory, including 3 currently open and 1,382 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to DUX PHARMA Unipessoal , LDA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Almada-Seixal, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €265. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.